Reevaluation of the importance of polymorphic HLA Class II Alleles and amino acids in the susceptibility of individuals of different populations to type I diabetes

American Journal of Medical Genetics

Volumn 76, Issue 2, 1998, Pages 183-194

  Zamani, Mahdi ^a   Cassiman, Jean Jacques ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Diabetes; DQB; DRB; HLA class II; Polymorphism; Risk assessment

Indexed keywords

AMINO ACID; HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DR ANTIGEN;

ACCURACY; ALLELE; ARTICLE; CHROMOSOME 6P; CONTROLLED STUDY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HLA SYSTEM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ALLELES; AMINO ACIDS; DIABETES MELLITUS, TYPE 1; DISEASE SUSCEPTIBILITY; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; MALE; POLYMORPHISM, GENETIC;

GENETTA;

EID: 0032485319     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19980305)76:2<183::AID-AJMG12>3.0.CO;2-H     Document Type: Article

References (87)

1. Ashton-Rickardt PG, Bandeira A, Delaney JR, Kaer LV, Pircher HP, Zinkernagel RM, Tonegawa S (1994): Evidence for differential avidity model of T cell selection in the thymus. Cell 76:651-663.
2. Awata T, Kanazawa Y (1994): Genetic marker for insulin-dependent diabetes mellitus in Japanese. Diabetes Res and Clin Pract 24(Suppl):S83-S87.
3. Awata T, Kuzuya T, Matsuda A, Iwamoto Y, Kanazawa Y, Okuyama M, Juji T (1989): High frequency of aspartic acid at position 57 of HLA-DQb-chain in Japanese IDDM patients and nondiabetic subjects. Diabetes 39:266-269.
4. Awata T, Kuzuya T, Matsuda A, Iwamoto Y, Kanazawa Y (1992): Genetic analysis of HLA class II alleles and susceptibility to type 1 (insulin-dependent) diabetes mellitus in Japanese subjects. Diabetologia 35: 419-424.
5. Bain SC, Prins JB, Hearne CM, Rodrigues NR, Rowe BR, Pritchard LE, Ritchie RJ, Hall JRS, Undlien DE, Ronningen KS, Dunger DB, Barnett AH, Todd JA (1992): Insulin gene encoded susceptibility to type 1 diabetes is not restricted to HLA-DR4-positive individuals. Nature Genet 2:212-215.
6. Baisch JM, Weeks T, Giles R, Hoover M, Stastny P, Capra JD (1990): Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes. N Engl J Med 322:1836-1841.
7. Bennett ST, Lucassen AM, Gough SCL, Powell EE, Undlien DE, Pritchard LE, Merriman ME, Kawaguchi Y, Dronsfield MJ, Pociot F, Nerup J, Bouzekri N, Cambon-Thomsen A, Ronningen KS, Barnett AH, Bain SC, Todd JA (1995): Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nature Genet 9:284-292.
8. Bodmer WF (1987): The HLA system: Structure and function. J Clin Pathol 40:948-958.
9. Brown JH, Jardetzky TS, Gorga JC, Stern LJ, Urban RG, Strominger JL, Wiley DC (1993): Three dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364:33-39.
10. Buyse I, Sandkuyl LA, Zamani M, Gu XX, Bouillon R, Bex M, Dooms L, Emonds MP, Duhamel M, Marynen P, Cassiman JJ (1994): Association of particular HLA class II alleles, haplotypes, and genotypes with susceptibility to insulin dependent diabetes mellitus in the Belgian population. Diabetologia 37:808-817.
11. Cavallo MG, Fava D, Monetini L, Barone F, Pozzilli P (1996): Cell-mediated immune response to β casein in recent-onset insulin-dependent diabetes: Implication for disease pathogenesis. Lancet 348: 926-928.
12. Copeman JB, Cucca F, Hearne CM, Cornall RJ, Reed PW, Ronningen KS, Undlien DE, Nistico L, Buzzetti R, Tosi R, Pociot F, Nerup J, Cornèlis F, Barnett AH, Bain SC, Todd JA (1995): Linkage disequilibrium mapping of type 1 diabetes susceptibility gene (IDDM7) to chromosome 2q31-q33. Nature Genet 9:80-85.
13. Coppin HL, Carmichael P, Lombard; G, L'Faqihi FE, Salter R, Parham P, Lechler RI, Preval C (1993): Position 71 in the a helix of the DRb domain is predicted to influence peptide binding and plays a central role in allorecognition. Eur J Immunol 23:343-349.
14. Cordell HJ, Todd JA (1995): Multifactorial inheritance in type 1 diabetes. Trends Genet 11:499-504.
15. Cucca F, Lampis R, Frau F, Macis D, Anguis E, Masile P, Chessa M, Frongia P, Silvetti M, Cao A, De Virgiliis S, Congia M (1995): The distribution of DR4 haplotypes in Sardinia suggests a primary association of type I diabetes with DRB1 and DQB1 loci. Hum Immunol 43: 301-308.
16. Cucca F, Muntoni F, Lampis R, Frau F, Argiolas L, Silvetti M, Angius E, Cao A, Virgiliis SD, Congia M (1993): Combination of specific DRB1, DQA1, DQB1 haplotype are associated with insulin dependent mellitus. Hum Immunol 37:85-94.
17. Cudworth A, Woodrow J (1974): HL-A system and diabetes mellitus. Diabetes 24:345-349.
18. Davies JL, Kawaguchi Y, Bennett ST, Copeman JB, Cordell HJ, Pritchard LE, Reed PW, Gough SCL, Jenkins SC, Palmer SM, Balfour KM, Rowe BR, Farrall M, Barnett AH, Bain SC, Todd JA (1994): A genome-wide search for human type 1 diabetes susceptibility genes. Nature 371:130-136.
19. DERI Group (Diabetes Epidemiology Research International Group) (1988): Geographical patterns of childhood insulin-dependent diabetes mellitus. Diabetes 37:1113-1119.
20. Deschamps I, Beressi JP, Khalil I, Robert JJ, Hors J (1991): The role of genetic predisposition to type I (insulin-dependent) diabetes mellitus. Ann Med 23:427-435.
21. 2 method. Am J Hum Genet 55:1042-1049.
22. Djoulah S, Khalil I, Beressi JP, Benhamamouch S, Bessaoud K, Deschamps I, Degos L, Hors J (1992): The HLA-DRB1*0405 haplotype is most strongly associated with IDDM in Algerians. Eur J Immunogene 19:381-389.
23. Dorman JS, LaPorte RE, Stone RA, Trucco M (1990): Worldwide differences in the incidence of type I diabetes are associated with amino acid variation at position 57 of the HLA-DQb chain. Proc Natl Acad Sci USA 87:7370-7374.
24. Easteal S, Kohonen-Corish MR, Zimmet P, Serjeantson SW (1990): HLA-DP variation as additional risk factor in IDDM. Diabetes 39:855-857.
25. Elston RC, Johnson WD (1994): "Essentials of Biostatistics." Second Edition. Philadelphia: F.A. Davis Company, pp 49-50.
26. Eisenbarth GS (1994): Mouse or man. Is GAD the cause of type I diabetes? Diabetes Care 17:605-607.
27. Fernandez-Vina M, Ramirez LC, Raskin P, Stastny P (1993): Genes for insulin-dependent diabetes mellitus (IDDM) in the major histocompatibility complex (MHC) of African-American. Tissue Antigens 41:57-64.
28. Field LL, Tobias R, Magnus T (1994): A locus on chromosome 15q26 (IDDM3) produced susceptibility to insulin-dependent diabetes mellitus. Nature Genet 8:189-194.
29. Foster DW (1989): Diabetes mellitus. In Scriver CR, Beaudet AL, Sly WS and Valle D (eds): "The Metabolic Basis of Inherited Disease." Sixth Edition. New York: McGjaw-Hill, pp 375-397.
30. Germain RN (1994): MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76: 287-299.
31. Ghosh P, Amaya M, Mellins E, Wiley DC (1995): The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature 378:457-462.
32. Giphart MJ, Roep BO, Drabbels J, D'Amaro J, Bruining J, Abdulkadir J, Verduyn W (1992): Relative contribution of HLA-DQA and DQB alleles to predisposition to insulin-dependent diabetes mellitus. Hum Immunol 34:142-146.
33. Green A, Gale EAM, and Patterson CC for the EURODIAB ACE study group (1992): Incidence of childhood-onset insulin-dependent diabetes mellitus: The EURODIAB ACE study. Lancet 339:905-909.
34. Hammer J, Valsasnini P, Tolba K, Bolin D, Higelin J, Takacs B, Sinigaglia F (1993): Promiscuous and allele-specific anchors in HLA-DR-binding peptides. Cell 74:197-203.
35. Harrison LC (1992): Islet cell autoantigen in insulin-dependent diabetes: Pandora's box revisited. Immunol Today 13:348-352.
36. Hashimoto L, Habita C, Beressi JP, Delepine M, Besse C, Cambon-Thomsen A, Deschamps I, Rotter JI, Djoulah S, James MR, Froguel P, Weissenbach J, Lathrop GM, Julier C (1994): Genetic mapping of a susceptibility locus for insulin-dependent diabetes mellitus on chromosome 11q. Nature 371:161-163.
37. Hogquist K, Jameson SC, Heath WR, Howard JL, Bevan MJ, Carbone FR (1994): T cell receptor antagonist peptides induce positive selection. Cell 76:17-27.
38. Hu CY, Allen M, Chuang LM, Lin BJ, Gyllensen U (1993): Association of insulin dependent diabetes mellitus in Taiwan with HLA class II DQB1 and DRB1 alleles. Hum Immunol 38:105-114.
39. Jacobs KH, Jenkins D, Mijovic C, Penny M, Uchigata Y, Cavan D, Hirata Y, Otani T, Fletcher J, Barnett AH (1992): An investigation of Japanese subjects maps susceptibility to type 1 (insulin-dependent) diabetes mellitus close to the DQA1 gene. Hum Immunol 33:24-28.
40. Julier C, Hyer RN, Davies J, Merlin F, Soularue P, Briant L, Cathelineau G, Deschamps I, Rotter JI, Froguel P, Boitard C, Bell JI, Lathrop GM (1991): Insulin-IGF2 region on chromosome lip encodes a gene implicated in HLA-DR4-dependent diabetes susceptibility. Nature 354:155-159.
41. Kappes D, Strominger JL (1988): Human class II Major histocompatibility complex genes and proteins. Ann Rev Biochem 57:991-1028.
42. Khalil I, Auriol L, Gobet M, Morin L, Lepage V, Deschamps I, Park MS, Degos L, Galibert F, Hors J (1990): A combination of HLA-DQb Asp57-Negative and HLA DQa Arg52 confers susceptibility to insulin-dependent diabetes mellitus. J Clin Invest 85:1315-1319.
43. Khalil I, Spyropoulou M, Mallet C, Loste MN, Douay C, Laperriere J, Bartzokas C, Lepage V, Charron D, Stavropoulos C (1993): HLA class II polymorphism and IDDM susceptibility in the Greek population. Eur J Immunogenet 20:193-199.
44. Krieger JI, Karr RW, Grey HM, Yu WY, O'Sullivan D, Batovsky L, Zheng ZL, Colon SM, Gaeta FCA, Sidney J, Albertson M, Guercio MF, Chesnut RW, Sette A (1991): Single amino acid changes in DR and antigen define residues critical for peptide-MHC binding and T cell recognition. J Immunol 146:2331-2340.
45. Kristiansen OP, Zamani M, Johannesen J, Mandrup-Poulsen T, Cassiman JJ, Nerup J, Pociot F, DIEGG, DSGD (1997): Linkage between a CD4 gene polymorphism and IDDM in Danish IDDM patients. Diabetes (submitted).
46. La Porte RE, Tajima N, Akerblom HK, Berlin N, Brosseau J, Christy M, Drash AL, Fishbein H, Green A, Hamman R, Harris M, King H, Laron Z, Neil A (1985): Geographic differences in the risk of insulin-dependent diabetes mellitus: The importance of registries. Diabetes Care 8:101-107.
47. Lohmann T, Leslie RDG, Hawa M, Geysen M, Rodda S, Londei M (1994): Immunodominant epitopes of glutamic acid decarboxylase 65 and 67 in insulin-dependent diabetes mellitus. Lancet 343:1607-1608.
48. Lucassen AM, Julier C, Beressi JP, Boitard C, Froguel P, Lathrop M, Bell JI (1993): Susceptibility to insulin dependent diabetes mellitus maps to a 4.1 Kb segment of DNA spanning the insulin gene and associated VNTR. Nature Genet 4:305-310.
49. Luo DF, Bui MM, Muir A, Maclaren NK, Thomson G, She JX (1995): Affected-sib-pair mapping of novel susceptibility gene to insulin-dependent diabetes mellitus (IDDM8) on chromosome 6q25-q27. Am J Hum Genet 57:911-919.
50. Luo DF, Buzzetti R, Rotter JI, Maclaren NK, Raffel LJ, Nistico L, Giovannini C, Pozzilli P, Thomson G, She JX (1996): Confirmation of three susceptibility gene to insulin-dependent diabetes mellitus: IDDM4, IDDM5 and IDDM8. Hum Mol Genet 5:693-698.
51. Magzoub MM, Stephens HA, Sachs JA, Biro PA, Curbush S, Wu Z, Bottazzo GF (1992): HLA-DP polymorphism in Sudanese controls and patients with insulin-dependent diabetes mellitus. Tissue Antigens 40: 64-68.
52. Marrack P, Parker DC (1994): A little of what you fancy. Nature 368:397-398.
53. Marsh SGE, Bodmer JG (1992): HLA class II nucleotide sequences, 1992. Tissue Antigens 40:229-243.
54. Moller E, Bohme J, Abedi Valugerdi M, Ridderstad A, Olerup O (1990): Speculations on mechanisms of HLA associations with autoimmune diseases and the specificity of "autoreactive" T lymphocytes. Immunol Rev 118:5-19.
55. Morel PA, Dorman JS, Todd JA, McDevitt HO (1988): Aspartic acid at position 57 HLA-DQ b Chain protect against type I diabetes. A family study. Proc Natl Acad Sci USA 85:8111-3115.
56. Muntoni S, Songini M, Sardinian collaborative group for epidemiology of IDDM (1992): High incidence rate of IDDM in Sardinia. Diabetes Care 5:1317-1322.
57. Nepom GT (1990): A unified hypothesis for the complex genetics of HLA association with IDDM. Diabetes 39:1153-1157.
58. Nerup J, Platz P, Andersen OO, Christy M, Lyngsoe J, Poulsen JE, Ryder LP, Nielsen LS, Thomsen M, Svejgaard A (1974): HLA antigens and diabetes mellitus. Lancet 2:864-866.
59. Noble JA, Valdes AM, Cook M, Klitz W, Thomson G, Erlich HA (1996): The role of HLA class II genes in insulin-dependent diabetes mellitus: Molecular analysis of 180 Caucasian, multiplex families. Am J Hum Genet 59:1134-1148.
60. Payton MA, Hawkes CJ, Christie MR (1995): Relationship of the 37,000 and 40,000 tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512). J Clin Invest 96:1506-1511.
61. Penny MA, Jenkins D, Mijovic CH, Jacobs KH, Cavan DA, Yeung VTF, Cockram CS, Hawkins BR, Fletcher JA, Barnett AH (1992): Susceptibility to IDDM in a Chinese population. Diabetes 41:914-919.
62. Powers AC, Bowen S, West S (1991): Carboxypeptidase H is an autoantigen of the ICA and is expressed on the cell surface of islet cells. Diabetes 40: 1A.
63. Rabin DU, Pleasic SM, Shapiro JA, Yoo-Warren H, Olse J, Hicks JM, Goldstein DE, Rae PM (1994): Islet cell antigen 512 is a diabetics specific islet autoantigen related to protein tyrosine phosphatase. J Immunol 152:3183-3188.
64. Ronningen KS, Spurkland A, Iwe T, Vartdal F, Thorsby E (1991): Distribution of HLA-DRB1, -DQA1 and -DQB1 alleles and DQA1-DQB1 genotypes among Norwegian patients with insulin dependent diabetes mellitus. Tissue Antigens 37:105-111.
65. Ronningen KS, Spurkland A, Tait BD, Drummond B, Lopez-Larrea C, Baranada FS, Menendez-Diaz MJ, Caillat-Zucman S, Beaurain G, Garchon HJ, Ilonen J, Reijonen H, Knip M, Boehm BO, Rosak C, Loliger C, Huhnl P, Ottenhoff T, Contu L, Carcassi C, Savi M, Zanelli P, Neri TM, Hamaguchi K, Kimura A, Dong RP, Chikuba N, Nagataki S, Gorodezky C, Bebaz H, Robles C, Coimbra HB, Martinho A, Ruas MA, Sachs JA, Garcia-Pachedo M, Biro A, Nikaein A, Dombrausky L, Gonwa T, Zmijewski C, Monos D, Kamoun M, Layrisse Z, Magli MC, Balducci P, Thorsby E (1992): "HLA Class II Association in Insulin-Dependent Diabetes Mellitus Among Black, Caucasoids, and Japanese." HLA 1991. New York: Oxford University Press, pp 713-722.
66. Sabbah E, Kulmala P, Veijola R, Vahasalo P, Karjalainen J, Tuomilehto-Wolf E, Akerblom HK, Knip M (1996): Glutamic acid decarboxylase antibodies in relation to other autoantibodies and genetic risk markers in children with newly diagnosed insulin-dependent diabetes. Childhood diabetes in Finland study group. J Clin Endocrinol Metabol 81: 2455-2459.
67. Sebzda E, Wallace VA, Mayer J, Yeung RSM, Mak TW, Ohashi PS (1994): Positive negative thymocyte selection induced by different concentrations of a single peptide. Science 263:1615-1618.
68. Serjeantson SW, Kohonen-Corish MRJ, Rowley MJ, Mackay IR, Knowles W, Zimmet P (1992): Antibody to glutamic acid decarboxylase are associated with HLA-DR genotype in both Australians and Asians with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 35:996-1001.
69. She J-X (1996): Susceptibility to type I diabetes: HLA-DQ and DR revisited. Immunol Today 17:323-329.
70. Sheehy MJ (1992): HLA and insulin-dependent diabetes. A protective prospective. Diabetes 41:123-129.
71. Solimena M, Dirkx RJ, Hermel JM, Pleasic-Williams S, Shapiro JA, Caron L, Rabin DU (1996): ICA 512, an autoantigen of type I diabetes, is an intrinsic membrane protein of neurosecretory granules. EMBO J 15: 2102-2114.
72. Stern LJ, Brown JH, Jardetzky TS, Gorga JC, Urban RG, Strominger JL, Wiley DC (1994): Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368:215-221.
73. Thomson G, Robinson WP, Kuhner MK, Joe S, MacDonald MJ, Gottschall JL, Barbosa J, Rich SS, Bertrams J, Baur MP, Partanen J, Tait BD, Schober E, Mayer WR, Ludvigsson J, Lindblom B, Farid NR, Thomson C, Deschamps I (1988): Genetic heterogeneity, modes of inheritance, and risk estimates for a joint study of Caucasian insulin dependent diabetes mellitus. Am J Hum Genet 43:799-816.
74. Thorsby E, Gjertsen HA, Lundin KA, Ronningen KS (1991): Insulin dependent diabetes mellitus susceptibility or protection may be determined by certain HLA-DQ molecules. Baillières Clin Endocrinol Metabol 5: 365-373.
75. Thorsby E, Ronningen KS (1993): Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to type 1 (insulin-dependent) diabetes mellitus. Diabetologia 36:371-377.
76. Tisch R, McDevitt H (1996): Insulin-dependent diabetes mellitus. Cell 85: 291-297.
77. Todd JA, Bell JI, McDevitt HO (1987): HLA-DQ beta gene contributed to susceptibility and resistance to insulin dependent diabetes mellitus. Nature 329:599-604.
78. Todd JA, Mijovic C, Fletcher J, Jenkins D, Bradwell AR, Barnett AH (1989): Identification of the susceptibility loci for insulin-dependent diabetes mellitus by trans-racial gene mapping. Nature 338:587-589.
79. Tuomilehto J, Zimmet P, Mackay IR, Koskela P, Vidgren G, Toivanen L, Tuomilehto-Wolf E, Kohtamäki K, Stengárd J, Rowley M (1994): Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease. Lancet 343:1383-1385.
80. Vaarala O, Klemetti P, Savilahti E, Reijonen H, Ilonen J, Akerblom HK (1996): Cellular immune response to cow's β-lactoglobulin in patients with newly diagnosed IDDM. Diabetes 45:178-182.
81. Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Jackson RA, Chase HP, Eisenbarth GS (1996): Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD and ICA512bdc/ IA-2 autoantibodies. Diabetes 45:926-933.
82. Wolf E, Spencer KM, Cudworth AG (1983): The genetic susceptibility to type 1 (insulin-dependent) diabetes: analysis of HLA-DR association. Diabetologia 24:224-230.
83. Wucherpfenning, Strominger (1995): Selective binding of self peptides to disease associated major histocompatibility complex (MHC) molecules: A mechanism for MHC-linked susceptibility to human autoimmune diseases. J Exp Med 181:1597-1601.
84. Zamani M, Spaepen M, Buyse I, Marynen P, Bex M, Bouillon R, Cassiman JJ (1994a): Improved risk assessment for IDDM by analysis of amino acids in HLA-DQ and DRβ1 loci. Eur J Hum Genet 2:177-184.
85. Zamani M, Buyse I, Legius E, Decorte R, Marynen P, Bouillon R, Cassiman JJ (1994b): Possible association of CD3 and CD4 polymorphisms with insulin-dependent diabetes mellitus (IDDM). Clin Exp Immunol 97: 517-521.
86. Lys71+ and IDDM. J Med Genet 33:899-905.
87. Zamani M, Flemming P, Raeymaekers P, Nerup J, Cassiman JJ (1996): Linkage of type I diabetes to 15q26 (IDDM3) in the Danish population. Hum Genet 98:491-496.